Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
drugs
5
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
5
×
fda
san diego blog main
san diego top stories
boston
clinical trials
san francisco blog main
san francisco top stories
akcea therapeutics
alnylam pharmaceuticals
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
inotersen
merck
national
patisiran
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
tafamidis
texas top stories
wisconsin blog main
wisconsin top stories
allopregnanolone
arvinas
barry greene
What
medicine
5
×
fda
drug
alnylam
approved
cells
new
oks
rna
time
uses
adapt
ago
approve
approves
awaits
biological
brexanolone
cancer
cellular
changes
crossed
decades
decision
deeper
depression
devastating
discovered
disorder
dna
ema
employ
europe
fast
fingerprint
fingers
follows
friday
gene
genetic
Language
unset
Current search:
drugs
×
medicine
×
" new york top stories "
×
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision